When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MRK - Esperion's Multiple Positives And Other News: The Good Bad And Ugly Of Biopharma
Merck & Company Inc.
Esperion Therapeutics Anticipates Positive News For Two Of Its Drug Candidates
Esperion Therapeutics (ESPR) is on the verge of a major catalyst as the company awaits the FDA decision for bempedoic acid as a treatment for increased LDL cholesterol. The agency is scheduled to deliver its verdict on February 21, 2020. The drug is also awaiting the FDA's decision for its use in conjunction with ezetimibe. The latter combination will receive the FDA verdict on February 26, 2020. Both the treatments are aimed at controlling LDL-C while in the combination therapy, the acid